University of California, San Francisco

Innovative Diabetes Researcher Joins National Academy of Sciences

Mark Anderson, MD, PhD, a pioneer in diabetes research and professor of medicine at UCSF, has been elected to the National ...
University of California, San Francisco

Improving Prediction of Alzheimer’s Disease with AI

A team at UCSF developed a multitask deep learning framework that can effectively predict Alzheimer’s disease diagnosis, cognitive scores, and future cognitive decline using only baseline MRI and ...
University of California, San Francisco

Health Coaches Improve Outcomes for Patients with Asthma and COPD

Pairing vulnerable, low-income patients with asthma coaches can improve outcomes and may also reduce costs associated with ...
University of California, San Francisco

How to Overcome Global Price Barriers for New Alzheimer’s Drugs

In the last few years, progress has been made in the fight against Alzheimer’s disease with a class of therapies called anti-amyloid antibodies (anti-Aβ). These anti-Aβ therapies, like lecanumab ...
University of California, San Francisco

The Liver’s Immune Cells Might Be the Key to Curing Hepatitis B

Jody Baron and Gabi Fragiadakis discover why some people with chronic Hepatitis B are cured after they're taken off of ...
University of California, San Francisco

Why Measles Is Spreading Again and Who Faces the Highest Risk

UCSF expert Charles Chiu discusses rising measles cases, extreme contagiousness, and why 95% vaccination rates are vital for ...
University of California, San Francisco

This Anti-CRISPR Stops the Protein Assembly Line in Bacteria

Joe Bondy-Denomy solves a CRISPR caper: this is how a viral protein stows itself on protein factories in bacteria, and destroys a CRISPR protein, designed to kill viruses, while it's being made.